Evaluation of leflunomide for the treatment of BK viremia and biopsy proven BK nephropathy; a single center experience.

نویسندگان

  • Nicole Nesselhauf
  • Jaclyn Strutt
  • Bahar Bastani
چکیده

BACKGROUND BK virus reactivation is a significant complication following renal transplantation that can result in graft failure. Reduction of immunosuppression and substitution of leflunomide for mycophenolate mofetil (MMF) has been used to treat this entity. OBJECTIVES To evaluate the use of leflunomide in BK viremia (BKV) and biopsy proven BK nephropathy (BKN) in kidney and kidney-pancreas transplant recipients. PATIENTS AND METHODS We retrospectively reviewed 28 kidney and kidney-pancreas transplant recipients who had received leflunomide for BKV from January 2006 to November 2012. Demographics, time to BKV diagnosis, biopsy findings, rejection episodes, and laboratory data were recorded. RESULTS The average (mean ± SD) time to BKV from time of transplant was 316.1 ± 368.0 days (62-1708 days). At time of diagnosis, 64% of patients had their maintenance immunosuppression reduced. The indications for leflunomide administration were; BKV and biopsy proven acute rejection (BPAR) (50%), biopsy proven BKN (18%), or persistent BKV (25%). Therapeutic levels (50-100 mcg/mL) were achieved in only 54% of patients, and 60% of them had required a leflunomide dose of at least 60 mg/day. BK virus was cleared from the serum on average of 151 ± 145.2 days (17-476 days). At study commencement, 29% of patients had remained on leflunomide due to persistent BKV. CONCLUSIONS In our study, most patients required at least a 60 mg daily dose of leflunomide to achieve therapeutic levels and to clear the virus compared to the standard 40 mg daily dose. Delaying therapy may result in progressive BKV and BKN.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

BK Viremia among Iranian Renal Transplant Candidates

Background: Primary infection with BK virus (BKV) is occurred during childhood and usually asymptomatic, but after initial infection, BKV may persist lifelong in the kidney and genitourinary tract. Reactivation may occur in individuals with compromised immunity such as renal transplant recipients. Due to the role of BKV in BK virus-associated nephropathy (BKVAN) and po...

متن کامل

Clearance of BK Virus Nephropathy by Combination Antiviral Therapy With Intravenous Immunoglobulin

BACKGROUND Reactivation of BK polyoma virus causes a destructive virus allograft nephropathy (BKVAN) with graft loss in 46%. Treatment options are limited to reduced immunosuppression and largely ineffective antiviral agents. Some studies suggest benefit from intravenous immunoglobulin (IVIG). METHODS We evaluated effectiveness of adjuvant IVIG to eliminate virus from blood and tissue, in a r...

متن کامل

A Case of BK Nephropathy without Detectable Viremia or Viruria

BACKGROUND BK nephropathy is an evolving challenge among kidney transplant recipients. Diagnosis of BK nephropathy depends on the presence of BK viral inclusions on renal biopsy. Most cases of BK nephropathy are preceded by BK viremia or viruria. CASE REPORT We report a case of BK nephropathy found on protocol renal transplant biopsy without associated BK viremia or viruria. CONCLUSIONS BK ...

متن کامل

Treatment of Polyomavirus-Associated Nephropathy With the Association of Sirolimus and Leflunomide.

Polyomavirus-associated nephropathy (PVAN) is an important cause of graft failure, affecting up to 10% of renal transplant patients.1 Fifty percent of polyomavirus viremia occur in the first 3 months, and 95% in the first 2 years after transplant.1 In the early reports, up to 50% of viremia resulted in graft loss.2,3 Polymerase chain reaction (PCR) BK virus viremia is a sensitive and specific m...

متن کامل

بررسی فراوانی نفروپاتی ناشی از ویروس BK در نمونه های بیوپسی

  A Ghafari Moghaddam [1] , MD M Taghizadieh [2] , MD N Aghakhani [3] , MD N Ebrahimi [4] , MD E Rahimi [5] , MDM Ghasemi-rad [6] , MD, S Zafarshams pour [7] , MD    Received: 29 April, 2007 Accepted: 29 Oct, 2008 Abstract  Background &Aims: BK virus nephropathy is recognized as a cause of graft loss in renal transplant patients. The disorder may be related to the introduction of new, potent im...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of nephropathology

دوره 5 1  شماره 

صفحات  -

تاریخ انتشار 2016